This inventor holds 3 USPTO granted patents. Top assignee: Redpoint Bio Corporation. Active years: 2010-2012.
Location History:
- Yardley, PA (US) (2011)
- Newtown, PA (US) (2010 - 2012)
Company Filing History:
Years Active: 2010-2012
Title: Innovations and Contributions of S Paul Lee
Introduction
S Paul Lee is an accomplished inventor based in Newtown, PA (US). He has made significant contributions to the field of biomedical research, particularly in the area of diabetes treatment and ion channel modulation. With a total of 3 patents to his name, Lee's work has the potential to impact the lives of many individuals suffering from metabolic disorders.
Latest Patents
One of Lee's latest patents is titled "Use of a TRPM5 inhibitor to regulate insulin and GLP-1 release." This invention focuses on methods to enhance insulin release, GLP-1 release, and insulin sensitivity. It also addresses methods for increasing insulin gene expression, decreasing gastric secretion and emptying, and inhibiting food intake. The patent outlines a treatment approach for diabetes mellitus, insulin resistance syndrome, hyperglycemia, and obesity through the administration of an effective amount of a TRPM5 inhibitor.
Another notable patent is the "Non-desensitizing mutant of the transient receptor potential TRPM5 ion channel." This invention responds to the need for high throughput screening assays that can identify compounds that specifically modulate the activity of fast-acting ion channels like TRPM5. The methods and compositions described provide improved electrophysiology techniques that allow for prolonged sample testing and offer rapid readouts with high signal-to-noise ratios.
Career Highlights
S Paul Lee is currently associated with Redpoint Bio Corporation, where he continues to innovate and develop new solutions in the biomedical field. His work is characterized by a commitment to advancing scientific understanding and improving therapeutic options for patients.
Collaborations
Lee collaborates with notable colleagues, including M N Tulu Buber and Robert Bryant, who contribute to his research endeavors and help drive innovation within the company.
Conclusion
S Paul Lee's contributions to the field of biomedical research through his patents and collaborations highlight his dedication to improving health outcomes. His innovative approaches to diabetes treatment and ion channel modulation are paving the way for future advancements in medical science.